1 Study Coverage 1.1 Foot and Mouth Disease (FMD) Vaccines Product Introduction 1.2 Market by Type 1.2.1 Global Foot and Mouth Disease (FMD) Vaccines Market Size Growth Rate by Type 1.4.2 Emergency Vaccines 1.4.3 Conventional Vaccines 1.3 Market by Application 1.3.1 Global Foot and Mouth Disease (FMD) Vaccines Market Size Growth Rate by Application 1.3.2 Cattle 1.3.3 Pig 1.3.4 Sheep & Goat 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Foot and Mouth Disease (FMD) Vaccines Sales Estimates and Forecasts 2016-2027 2.2 Global Foot and Mouth Disease (FMD) Vaccines Revenue Estimates and Forecasts 2016-2027 2.3 Global Foot and Mouth Disease (FMD) Vaccines Revenue by Region: 2016 VS 2021 VS 2027 2.4 Global Top Foot and Mouth Disease (FMD) Vaccines Regions by Sales 2.4.1 Global Top Foot and Mouth Disease (FMD) Vaccines Regions by Sales (2016-2021) 2.4.2 Global Top Foot and Mouth Disease (FMD) Vaccines Regions by Sales (2022-2027) 2.5 Global Top Foot and Mouth Disease (FMD) Vaccines Regions by Revenue 2.5.1 Global Top Foot and Mouth Disease (FMD) Vaccines Regions by Revenue (2016-2021) 2.5.2 Global Top Foot and Mouth Disease (FMD) Vaccines Regions by Revenue (2022-2027) 2.6 North America 2.7 Europe 2.8 Asia-Pacific 2.9 Latin America 2.10 Middle East & Africa 3 Competition by Manufacturers 3.1 Global Foot and Mouth Disease (FMD) Vaccines Sales by Manufacturers 3.1.1 Global Top Foot and Mouth Disease (FMD) Vaccines Manufacturers by Sales (2016-2021) 3.1.2 Global Top Foot and Mouth Disease (FMD) Vaccines Manufacturers Market Share by Sales (2016-2021) 3.1.3 Global Top 10 and Top 5 Companies by Foot and Mouth Disease (FMD) Vaccines Sales in 2020 3.2 Global Foot and Mouth Disease (FMD) Vaccines Revenue by Manufacturers 3.2.1 Global Top Foot and Mouth Disease (FMD) Vaccines Manufacturers by Revenue (2016-2021) 3.2.2 Global Top Foot and Mouth Disease (FMD) Vaccines Manufacturers Market Share by Revenue (2016-2021) 3.2.3 Global Top 10 and Top 5 Companies by Foot and Mouth Disease (FMD) Vaccines Revenue in 2020 3.3 Global Foot and Mouth Disease (FMD) Vaccines Sales Price by Manufacturers 3.4 Analysis of Competitive Landscape 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Foot and Mouth Disease (FMD) Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4.3 Global Foot and Mouth Disease (FMD) Vaccines Manufacturers Geographical Distribution 3.5 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Global Foot and Mouth Disease (FMD) Vaccines Sales by Type 4.1.1 Global Foot and Mouth Disease (FMD) Vaccines Historical Sales by Type (2016-2021) 4.1.2 Global Foot and Mouth Disease (FMD) Vaccines Forecasted Sales by Type (2022-2027) 4.1.3 Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Type (2016-2027) 4.2 Global Foot and Mouth Disease (FMD) Vaccines Revenue by Type 4.2.1 Global Foot and Mouth Disease (FMD) Vaccines Historical Revenue by Type (2016-2021) 4.2.2 Global Foot and Mouth Disease (FMD) Vaccines Forecasted Revenue by Type (2022-2027) 4.2.3 Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Type (2016-2027) 4.3 Global Foot and Mouth Disease (FMD) Vaccines Price by Type 4.3.1 Global Foot and Mouth Disease (FMD) Vaccines Price by Type (2016-2021) 4.3.2 Global Foot and Mouth Disease (FMD) Vaccines Price Forecast by Type (2022-2027) 5 Market Size by Application 5.1 Global Foot and Mouth Disease (FMD) Vaccines Sales by Application 5.1.1 Global Foot and Mouth Disease (FMD) Vaccines Historical Sales by Application (2016-2021) 5.1.2 Global Foot and Mouth Disease (FMD) Vaccines Forecasted Sales by Application (2022-2027) 5.1.3 Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Application (2016-2027) 5.2 Global Foot and Mouth Disease (FMD) Vaccines Revenue by Application 5.2.1 Global Foot and Mouth Disease (FMD) Vaccines Historical Revenue by Application (2016-2021) 5.2.2 Global Foot and Mouth Disease (FMD) Vaccines Forecasted Revenue by Application (2022-2027) 5.2.3 Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Application (2016-2027) 5.3 Global Foot and Mouth Disease (FMD) Vaccines Price by Application 5.3.1 Global Foot and Mouth Disease (FMD) Vaccines Price by Application (2016-2021) 5.3.2 Global Foot and Mouth Disease (FMD) Vaccines Price Forecast by Application (2022-2027) 6 North America 6.1 North America Foot and Mouth Disease (FMD) Vaccines Market Size by Type 6.1.1 North America Foot and Mouth Disease (FMD) Vaccines Sales by Type (2016-2027) 6.1.2 North America Foot and Mouth Disease (FMD) Vaccines Revenue by Type (2016-2027) 6.2 North America Foot and Mouth Disease (FMD) Vaccines Market Size by Application 6.2.1 North America Foot and Mouth Disease (FMD) Vaccines Sales by Application (2016-2027) 6.2.2 North America Foot and Mouth Disease (FMD) Vaccines Revenue by Application (2016-2027) 6.3 North America Foot and Mouth Disease (FMD) Vaccines Market Size by Country 6.3.1 North America Foot and Mouth Disease (FMD) Vaccines Sales by Country (2016-2027) 6.3.2 North America Foot and Mouth Disease (FMD) Vaccines Revenue by Country (2016-2027) 6.3.3 U.S. 6.3.4 Canada 7 Europe 7.1 Europe Foot and Mouth Disease (FMD) Vaccines Market Size by Type 7.1.1 Europe Foot and Mouth Disease (FMD) Vaccines Sales by Type (2017-2027) 7.1.2 Europe Foot and Mouth Disease (FMD) Vaccines Revenue by Type (2017-2027) 7.2 Europe Foot and Mouth Disease (FMD) Vaccines Market Size by Application 7.2.1 Europe Foot and Mouth Disease (FMD) Vaccines Sales by Application (2017-2027) 7.2.2 Europe Foot and Mouth Disease (FMD) Vaccines Revenue by Application (2017-2027) 7.3 Europe Foot and Mouth Disease (FMD) Vaccines Market Size by Country 7.3.1 Europe Foot and Mouth Disease (FMD) Vaccines Sales by Country (2017-2027) 7.3.2 Europe Foot and Mouth Disease (FMD) Vaccines Revenue by Country (2017-2027) 7.3.3 Germany 7.3.4 France 7.3.5 U.K. 7.3.6 Italy 7.3.7 Russia 8 Asia Pacific 8.1 Asia Pacific Foot and Mouth Disease (FMD) Vaccines Market Size by Type 8.1.1 Asia Pacific Foot and Mouth Disease (FMD) Vaccines Sales by Type (2018-2027) 8.1.2 Asia Pacific Foot and Mouth Disease (FMD) Vaccines Revenue by Type (2018-2027) 8.2 Asia Pacific Foot and Mouth Disease (FMD) Vaccines Market Size by Application 8.2.1 Asia Pacific Foot and Mouth Disease (FMD) Vaccines Sales by Application (2018-2027) 8.2.2 Asia Pacific Foot and Mouth Disease (FMD) Vaccines Revenue by Application (2018-2027) 8.3 Asia Pacific Foot and Mouth Disease (FMD) Vaccines Market Size by Region 8.3.1 Asia Pacific Foot and Mouth Disease (FMD) Vaccines Sales by Region (2018-2027) 8.3.2 Asia Pacific Foot and Mouth Disease (FMD) Vaccines Revenue by Region (2018-2027) 8.3.3 China 8.3.4 Japan 8.3.5 South Korea 8.3.6 India 8.3.7 Australia 8.3.8 Taiwan 8.3.9 Indonesia 8.3.10 Thailand 8.3.11 Malaysia 8.3.12 Philippines 9 Latin America 9.1 Latin America Foot and Mouth Disease (FMD) Vaccines Market Size by Type 9.1.1 Latin America Foot and Mouth Disease (FMD) Vaccines Sales by Type (2019-2027) 9.1.2 Latin America Foot and Mouth Disease (FMD) Vaccines Revenue by Type (2019-2027) 9.2 Latin America Foot and Mouth Disease (FMD) Vaccines Market Size by Application 9.2.1 Latin America Foot and Mouth Disease (FMD) Vaccines Sales by Application (2019-2027) 9.2.2 Latin America Foot and Mouth Disease (FMD) Vaccines Revenue by Application (2019-2027) 9.3 Latin America Foot and Mouth Disease (FMD) Vaccines Market Size by Country 9.3.1 Latin America Foot and Mouth Disease (FMD) Vaccines Sales by Country (2019-2027) 9.3.2 Latin America Foot and Mouth Disease (FMD) Vaccines Revenue by Country (2019-2027) 9.3.3 Mexico 9.3.4 Brazil 9.3.5 Argentina 6 Middle East and Africa 6.1 Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Market Size by Type 6.1.1 Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Sales by Type (2016-2027) 6.1.2 Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Revenue by Type (2016-2027) 6.2 Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Market Size by Application 6.2.1 Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Sales by Application (2016-2027) 6.2.2 Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Revenue by Application (2016-2027) 6.3 Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Market Size by Country 6.3.1 Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Sales by Country (2016-2027) 6.3.2 Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Revenue by Country (2016-2027) 6.3.3 Turkey 6.3.4 Saudi Arabia 6.3.5 U.A.E 11 Company Profiles 11.1 Jinyu Group 11.1.1 Jinyu Group Corporation Information 11.1.2 Jinyu Group Overview 11.1.3 Jinyu Group Foot and Mouth Disease (FMD) Vaccines Sales, Price, Revenue and Gross Margin (2016-2021) 11.1.4 Jinyu Group Foot and Mouth Disease (FMD) Vaccines Product Description 11.1.5 Jinyu Group Related Developments 11.2 Cavet Bio 11.2.1 Cavet Bio Corporation Information 11.2.2 Cavet Bio Overview 11.2.3 Cavet Bio Foot and Mouth Disease (FMD) Vaccines Sales, Price, Revenue and Gross Margin (2016-2021) 11.2.4 Cavet Bio Foot and Mouth Disease (FMD) Vaccines Product Description 11.2.5 Cavet Bio Related Developments 11.3 Indian Immunologicals 11.3.1 Indian Immunologicals Corporation Information 11.3.2 Indian Immunologicals Overview 11.3.3 Indian Immunologicals Foot and Mouth Disease (FMD) Vaccines Sales, Price, Revenue and Gross Margin (2016-2021) 11.3.4 Indian Immunologicals Foot and Mouth Disease (FMD) Vaccines Product Description 11.3.5 Indian Immunologicals Related Developments 11.4 Tecon Group 11.4.1 Tecon Group Corporation Information 11.4.2 Tecon Group Overview 11.4.3 Tecon Group Foot and Mouth Disease (FMD) Vaccines Sales, Price, Revenue and Gross Margin (2016-2021) 11.4.4 Tecon Group Foot and Mouth Disease (FMD) Vaccines Product Description 11.4.5 Tecon Group Related Developments 11.5 CAHIC 11.5.1 CAHIC Corporation Information 11.5.2 CAHIC Overview 11.5.3 CAHIC Foot and Mouth Disease (FMD) Vaccines Sales, Price, Revenue and Gross Margin (2016-2021) 11.5.4 CAHIC Foot and Mouth Disease (FMD) Vaccines Product Description 11.5.5 CAHIC Related Developments 11.6 Shen Lian 11.6.1 Shen Lian Corporation Information 11.6.2 Shen Lian Overview 11.6.3 Shen Lian Foot and Mouth Disease (FMD) Vaccines Sales, Price, Revenue and Gross Margin (2016-2021) 11.6.4 Shen Lian Foot and Mouth Disease (FMD) Vaccines Product Description 11.6.5 Shen Lian Related Developments 11.7 Biogenesis Bagó 11.7.1 Biogenesis Bagó Corporation Information 11.7.2 Biogenesis Bagó Overview 11.7.3 Biogenesis Bagó Foot and Mouth Disease (FMD) Vaccines Sales, Price, Revenue and Gross Margin (2016-2021) 11.7.4 Biogenesis Bagó Foot and Mouth Disease (FMD) Vaccines Product Description 11.7.5 Biogenesis Bagó Related Developments 11.8 BIGVET Biotech 11.8.1 BIGVET Biotech Corporation Information 11.8.2 BIGVET Biotech Overview 11.8.3 BIGVET Biotech Foot and Mouth Disease (FMD) Vaccines Sales, Price, Revenue and Gross Margin (2016-2021) 11.8.4 BIGVET Biotech Foot and Mouth Disease (FMD) Vaccines Product Description 11.8.5 BIGVET Biotech Related Developments 11.9 Boehringer Ingelheim 11.9.1 Boehringer Ingelheim Corporation Information 11.9.2 Boehringer Ingelheim Overview 11.9.3 Boehringer Ingelheim Foot and Mouth Disease (FMD) Vaccines Sales, Price, Revenue and Gross Margin (2016-2021) 11.9.4 Boehringer Ingelheim Foot and Mouth Disease (FMD) Vaccines Product Description 11.9.5 Boehringer Ingelheim Related Developments 11.10 MSD Animal Health 11.10.1 MSD Animal Health Corporation Information 11.10.2 MSD Animal Health Overview 11.10.3 MSD Animal Health Foot and Mouth Disease (FMD) Vaccines Sales, Price, Revenue and Gross Margin (2016-2021) 11.10.4 MSD Animal Health Foot and Mouth Disease (FMD) Vaccines Product Description 11.10.5 MSD Animal Health Related Developments 11.1 Jinyu Group 11.1.1 Jinyu Group Corporation Information 11.1.2 Jinyu Group Overview 11.1.3 Jinyu Group Foot and Mouth Disease (FMD) Vaccines Sales, Price, Revenue and Gross Margin (2016-2021) 11.1.4 Jinyu Group Foot and Mouth Disease (FMD) Vaccines Product Description 11.1.5 Jinyu Group Related Developments 11.12 FGBI 11.12.1 FGBI Corporation Information 11.12.2 FGBI Overview 11.12.3 FGBI Foot and Mouth Disease (FMD) Vaccines Sales, Price, Revenue and Gross Margin (2016-2021) 11.12.4 FGBI Product Description 11.12.5 FGBI Related Developments 11.13 Bayer HealthCare 11.13.1 Bayer HealthCare Corporation Information 11.13.2 Bayer HealthCare Overview 11.13.3 Bayer HealthCare Foot and Mouth Disease (FMD) Vaccines Sales, Price, Revenue and Gross Margin (2016-2021) 11.13.4 Bayer HealthCare Product Description 11.13.5 Bayer HealthCare Related Developments 11.14 Brilliant Bio Pharma 11.14.1 Brilliant Bio Pharma Corporation Information 11.14.2 Brilliant Bio Pharma Overview 11.14.3 Brilliant Bio Pharma Foot and Mouth Disease (FMD) Vaccines Sales, Price, Revenue and Gross Margin (2016-2021) 11.14.4 Brilliant Bio Pharma Product Description 11.14.5 Brilliant Bio Pharma Related Developments 11.15 VECOL 11.15.1 VECOL Corporation Information 11.15.2 VECOL Overview 11.15.3 VECOL Foot and Mouth Disease (FMD) Vaccines Sales, Price, Revenue and Gross Margin (2016-2021) 11.15.4 VECOL Product Description 11.15.5 VECOL Related Developments 11.16 Sanofi (Merial) 11.16.1 Sanofi (Merial) Corporation Information 11.16.2 Sanofi (Merial) Overview 11.16.3 Sanofi (Merial) Foot and Mouth Disease (FMD) Vaccines Sales, Price, Revenue and Gross Margin (2016-2021) 11.16.4 Sanofi (Merial) Product Description 11.16.5 Sanofi (Merial) Related Developments 11.17 VETAL 11.17.1 VETAL Corporation Information 11.17.2 VETAL Overview 11.17.3 VETAL Foot and Mouth Disease (FMD) Vaccines Sales, Price, Revenue and Gross Margin (2016-2021) 11.17.4 VETAL Product Description 11.17.5 VETAL Related Developments 11.18 BVI 11.18.1 BVI Corporation Information 11.18.2 BVI Overview 11.18.3 BVI Foot and Mouth Disease (FMD) Vaccines Sales, Price, Revenue and Gross Margin (2016-2021) 11.18.4 BVI Product Description 11.18.5 BVI Related Developments 11.19 LIMOR 11.19.1 LIMOR Corporation Information 11.19.2 LIMOR Overview 11.19.3 LIMOR Foot and Mouth Disease (FMD) Vaccines Sales, Price, Revenue and Gross Margin (2016-2021) 11.19.4 LIMOR Product Description 11.19.5 LIMOR Related Developments 11.20 ME VAC 11.20.1 ME VAC Corporation Information 11.20.2 ME VAC Overview 11.20.3 ME VAC Foot and Mouth Disease (FMD) Vaccines Sales, Price, Revenue and Gross Margin (2016-2021) 11.20.4 ME VAC Product Description 11.20.5 ME VAC Related Developments 11.21 Agrovet 11.21.1 Agrovet Corporation Information 11.21.2 Agrovet Overview 11.21.3 Agrovet Foot and Mouth Disease (FMD) Vaccines Sales, Price, Revenue and Gross Margin (2016-2021) 11.21.4 Agrovet Product Description 11.21.5 Agrovet Related Developments 12 Value Chain and Sales Channels Analysis 12.1 Foot and Mouth Disease (FMD) Vaccines Value Chain Analysis 12.2 Foot and Mouth Disease (FMD) Vaccines Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Foot and Mouth Disease (FMD) Vaccines Production Mode & Process 12.4 Foot and Mouth Disease (FMD) Vaccines Sales and Marketing 12.4.1 Foot and Mouth Disease (FMD) Vaccines Sales Channels 12.4.2 Foot and Mouth Disease (FMD) Vaccines Distributors 12.5 Foot and Mouth Disease (FMD) Vaccines Customers 13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 13.1 Foot and Mouth Disease (FMD) Vaccines Industry Trends 13.2 Foot and Mouth Disease (FMD) Vaccines Market Drivers 13.3 Foot and Mouth Disease (FMD) Vaccines Market Challenges 13.4 Foot and Mouth Disease (FMD) Vaccines Market Restraints 14 Key Findings in The Global Foot and Mouth Disease (FMD) Vaccines Study 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer

List of Tables Table 1. Global Foot and Mouth Disease (FMD) Vaccines Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of Emergency Vaccines Table 3. Major Manufacturers of Conventional Vaccines Table 4. Global Foot and Mouth Disease (FMD) Vaccines Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million) Table 5. Global Foot and Mouth Disease (FMD) Vaccines Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million) Table 6. Global Foot and Mouth Disease (FMD) Vaccines Sales by Region (2016-2021) & (K L) Table 7. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Region (2016-2021) Table 8. Global Foot and Mouth Disease (FMD) Vaccines Sales by Region (2016-2021) & (K L) Table 9. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Region (2022-2027) Table 10. Global Foot and Mouth Disease (FMD) Vaccines Revenue by Region (2016-2021) & (US$ Million) Table 11. Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Region (2016-2021) Table 12. Global Foot and Mouth Disease (FMD) Vaccines Revenue by Region (2022-2027) & (US$ Million) Table 13. Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Region (2022-2027) Table 14. Global Foot and Mouth Disease (FMD) Vaccines Sales by Manufacturers (2016-2021) & (K L) Table 15. Global Foot and Mouth Disease (FMD) Vaccines Sales Share by Manufacturers (2016-2021) Table 16. Global Foot and Mouth Disease (FMD) Vaccines Revenue by Manufacturers (2016-2021) & (US$ Million) Table 17. Global Foot and Mouth Disease (FMD) Vaccines Revenue Share by Manufacturers (2016-2021) Table 18. Foot and Mouth Disease (FMD) Vaccines Price by Manufacturers 2016-2021 (USD/L) Table 19. Global Foot and Mouth Disease (FMD) Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) Table 20. Global Foot and Mouth Disease (FMD) Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Foot and Mouth Disease (FMD) Vaccines as of 2020) Table 21. Foot and Mouth Disease (FMD) Vaccines Manufacturing Base Distribution and Headquarters Table 22. Manufacturers Foot and Mouth Disease (FMD) Vaccines Product Offered Table 23. Date of Manufacturers Enter into Foot and Mouth Disease (FMD) Vaccines Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Foot and Mouth Disease (FMD) Vaccines Sales by Type (2016-2021) & (K L) Table 26. Global Foot and Mouth Disease (FMD) Vaccines Sales by Type (2022-2027) & (K L) Table 27. Global Foot and Mouth Disease (FMD) Vaccines Sales Share by Type (2016-2021) Table 28. Global Foot and Mouth Disease (FMD) Vaccines Sales Share by Type (2022-2027) Table 29. Global Foot and Mouth Disease (FMD) Vaccines Revenue by Type (2016-2021) & (US$ Million) Table 30. Global Foot and Mouth Disease (FMD) Vaccines Revenue by Type (2022-2027) & (US$ Million) Table 31. Global Foot and Mouth Disease (FMD) Vaccines Revenue Share by Type (2016-2021) Table 32. Global Foot and Mouth Disease (FMD) Vaccines Revenue Share by Type (2022-2027) Table 33. Foot and Mouth Disease (FMD) Vaccines Price by Type (2016-2021) & (USD/L) Table 34. Global Foot and Mouth Disease (FMD) Vaccines Price Forecast by Type (2022-2027) & (USD/L) Table 35. Global Foot and Mouth Disease (FMD) Vaccines Sales by Application (2016-2021) & (K L) Table 36. Global Foot and Mouth Disease (FMD) Vaccines Sales by Application (2022-2027) & (K L) Table 37. Global Foot and Mouth Disease (FMD) Vaccines Sales Share by Application (2016-2021) Table 38. Global Foot and Mouth Disease (FMD) Vaccines Sales Share by Application (2022-2027) Table 39. Global Foot and Mouth Disease (FMD) Vaccines Revenue by Application (2016-2021) & (US$ Million) Table 40. Global Foot and Mouth Disease (FMD) Vaccines Revenue by Application (2022-2027) & (US$ Million) Table 41. Global Foot and Mouth Disease (FMD) Vaccines Revenue Share by Application (2016-2021) Table 42. Global Foot and Mouth Disease (FMD) Vaccines Revenue Share by Application (2022-2027) Table 43. Foot and Mouth Disease (FMD) Vaccines Price by Application (2016-2021) & (USD/L) Table 44. Global Foot and Mouth Disease (FMD) Vaccines Price Forecast by Application (2022-2027) & (USD/L) Table 45. North America Foot and Mouth Disease (FMD) Vaccines Sales by Type (2016-2021) & (K L) Table 46. North America Foot and Mouth Disease (FMD) Vaccines Sales by Type (2022-2027) & (K L) Table 47. North America Foot and Mouth Disease (FMD) Vaccines Revenue by Type (2016-2021) & (US$ Million) Table 48. North America Foot and Mouth Disease (FMD) Vaccines Revenue by Type (2022-2027) & (US$ Million) Table 49. North America Foot and Mouth Disease (FMD) Vaccines Sales by Application (2016-2021) & (K L) Table 50. North America Foot and Mouth Disease (FMD) Vaccines Sales by Application (2022-2027) & (K L) Table 51. North America Foot and Mouth Disease (FMD) Vaccines Revenue by Application (2016-2021) & (US$ Million) Table 52. North America Foot and Mouth Disease (FMD) Vaccines Revenue by Application (2022-2027) & (US$ Million) Table 53. North America Foot and Mouth Disease (FMD) Vaccines Sales by Country (2016-2021) & (K L) Table 54. North America Foot and Mouth Disease (FMD) Vaccines Sales by Country (2022-2027) & (K L) Table 55. North America Foot and Mouth Disease (FMD) Vaccines Revenue by Country (2016-2021) & (US$ Million) Table 56. North America Foot and Mouth Disease (FMD) Vaccines Revenue by Country (2022-2027) & (US$ Million) Table 57. Europe Foot and Mouth Disease (FMD) Vaccines Sales by Type (2016-2021) & (K L) Table 58. Europe Foot and Mouth Disease (FMD) Vaccines Sales by Type (2022-2027) & (K L) Table 59. Europe Foot and Mouth Disease (FMD) Vaccines Revenue by Type (2016-2021) & (US$ Million) Table 60. Europe Foot and Mouth Disease (FMD) Vaccines Revenue by Type (2022-2027) & (US$ Million) Table 61. Europe Foot and Mouth Disease (FMD) Vaccines Sales by Application (2016-2021) & (K L) Table 62. Europe Foot and Mouth Disease (FMD) Vaccines Sales by Application (2022-2027) & (K L) Table 63. Europe Foot and Mouth Disease (FMD) Vaccines Revenue by Application (2016-2021) & (US$ Million) Table 64. Europe Foot and Mouth Disease (FMD) Vaccines Revenue by Application (2022-2027) & (US$ Million) Table 65. Europe Foot and Mouth Disease (FMD) Vaccines Sales by Country (2016-2021) & (K L) Table 66. Europe Foot and Mouth Disease (FMD) Vaccines Sales by Country (2022-2027) & (K L) Table 67. Europe Foot and Mouth Disease (FMD) Vaccines Revenue by Country (2016-2021) & (US$ Million) Table 68. Europe Foot and Mouth Disease (FMD) Vaccines Revenue by Country (2022-2027) & (US$ Million) Table 69. Asia Pacific Foot and Mouth Disease (FMD) Vaccines Sales by Type (2016-2021) & (K L) Table 70. Asia Pacific Foot and Mouth Disease (FMD) Vaccines Sales by Type (2022-2027) & (K L) Table 71. Asia Pacific Foot and Mouth Disease (FMD) Vaccines Revenue by Type (2016-2021) & (US$ Million) Table 72. Asia Pacific Foot and Mouth Disease (FMD) Vaccines Revenue by Type (2022-2027) & (US$ Million) Table 73. Asia Pacific Foot and Mouth Disease (FMD) Vaccines Sales by Application (2016-2021) & (K L) Table 74. Asia Pacific Foot and Mouth Disease (FMD) Vaccines Sales by Application (2022-2027) & (K L) Table 75. Asia Pacific Foot and Mouth Disease (FMD) Vaccines Revenue by Application (2016-2021) & (US$ Million) Table 76. Asia Pacific Foot and Mouth Disease (FMD) Vaccines Revenue by Application (2022-2027) & (US$ Million) Table 77. Asia Pacific Foot and Mouth Disease (FMD) Vaccines Sales by Region (2016-2021) & (K L) Table 78. Asia Pacific Foot and Mouth Disease (FMD) Vaccines Sales by Region (2022-2027) & (K L) Table 79. Asia Pacific Foot and Mouth Disease (FMD) Vaccines Revenue by Region (2016-2021) & (US$ Million) Table 80. Asia Pacific Foot and Mouth Disease (FMD) Vaccines Revenue by Region (2022-2027) & (US$ Million) Table 81. Latin America Foot and Mouth Disease (FMD) Vaccines Sales by Type (2016-2021) & (K L) Table 82. Latin America Foot and Mouth Disease (FMD) Vaccines Sales by Type (2022-2027) & (K L) Table 83. Latin America Foot and Mouth Disease (FMD) Vaccines Revenue by Type (2016-2021) & (US$ Million) Table 84. Latin America Foot and Mouth Disease (FMD) Vaccines Revenue by Type (2022-2027) & (US$ Million) Table 85. Latin America Foot and Mouth Disease (FMD) Vaccines Sales by Application (2016-2021) & (K L) Table 86. Latin America Foot and Mouth Disease (FMD) Vaccines Sales by Application (2022-2027) & (K L) Table 87. Latin America Foot and Mouth Disease (FMD) Vaccines Revenue by Application (2016-2021) & (US$ Million) Table 88. Latin America Foot and Mouth Disease (FMD) Vaccines Revenue by Application (2022-2027) & (US$ Million) Table 89. Latin America Foot and Mouth Disease (FMD) Vaccines Sales by Country (2016-2021) & (K L) Table 90. Latin America Foot and Mouth Disease (FMD) Vaccines Sales by Country (2022-2027) & (K L) Table 91. Latin America Foot and Mouth Disease (FMD) Vaccines Revenue by Country (2016-2021) & (US$ Million) Table 92. Latin America Foot and Mouth Disease (FMD) Vaccines Revenue by Country (2022-2027) & (US$ Million) Table 93. Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Sales by Type (2016-2021) & (K L) Table 94. Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Sales by Type (2022-2027) & (K L) Table 95. Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Revenue by Type (2016-2021) & (US$ Million) Table 96. Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Revenue by Type (2022-2027) & (US$ Million) Table 97. Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Sales by Application (2016-2021) & (K L) Table 98. Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Sales by Application (2022-2027) & (K L) Table 99. Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Revenue by Application (2016-2021) & (US$ Million) Table 100. Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Revenue by Application (2022-2027) & (US$ Million) Table 101. Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Sales by Country (2016-2021) & (K L) Table 102. Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Sales by Country (2022-2027) & (K L) Table 103. Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Revenue by Country (2016-2021) & (US$ Million) Table 104. Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Revenue by Country (2022-2027) & (US$ Million) Table 105. Jinyu Group Corporation Information Table 106. Jinyu Group Description and Major Businesses Table 107. Jinyu Group Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2016-2021) Table 108. Jinyu Group Foot and Mouth Disease (FMD) Vaccines Product Table 109. Jinyu Group Recent Developments Table 110. Cavet Bio Corporation Information Table 111. Cavet Bio Description and Major Businesses Table 112. Cavet Bio Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2016-2021) Table 113. Cavet Bio Foot and Mouth Disease (FMD) Vaccines Product Table 114. Cavet Bio Recent Developments Table 115. Indian Immunologicals Corporation Information Table 116. Indian Immunologicals Description and Major Businesses Table 117. Indian Immunologicals Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2016-2021) Table 118. Indian Immunologicals Foot and Mouth Disease (FMD) Vaccines Product Table 119. Indian Immunologicals Recent Developments Table 120. Tecon Group Corporation Information Table 121. Tecon Group Description and Major Businesses Table 122. Tecon Group Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2016-2021) Table 123. Tecon Group Foot and Mouth Disease (FMD) Vaccines Product Table 124. Tecon Group Recent Developments Table 125. CAHIC Corporation Information Table 126. CAHIC Description and Major Businesses Table 127. CAHIC Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2016-2021) Table 128. CAHIC Foot and Mouth Disease (FMD) Vaccines Product Table 129. CAHIC Recent Developments Table 130. Shen Lian Corporation Information Table 131. Shen Lian Description and Major Businesses Table 132. Shen Lian Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2016-2021) Table 133. Shen Lian Foot and Mouth Disease (FMD) Vaccines Product Table 134. Shen Lian Recent Developments Table 135. Biogenesis Bagó Corporation Information Table 136. Biogenesis Bagó Description and Major Businesses Table 137. Biogenesis Bagó Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2016-2021) Table 138. Biogenesis Bagó Foot and Mouth Disease (FMD) Vaccines Product Table 139. Biogenesis Bagó Recent Developments Table 140. BIGVET Biotech Corporation Information Table 141. BIGVET Biotech Description and Major Businesses Table 142. BIGVET Biotech Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2016-2021) Table 143. BIGVET Biotech Foot and Mouth Disease (FMD) Vaccines Product Table 144. BIGVET Biotech Recent Developments Table 145. Boehringer Ingelheim Corporation Information Table 146. Boehringer Ingelheim Description and Major Businesses Table 147. Boehringer Ingelheim Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2016-2021) Table 148. Boehringer Ingelheim Foot and Mouth Disease (FMD) Vaccines Product Table 149. Boehringer Ingelheim Recent Developments Table 150. MSD Animal Health Corporation Information Table 151. MSD Animal Health Description and Major Businesses Table 152. MSD Animal Health Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2016-2021) Table 153. MSD Animal Health Foot and Mouth Disease (FMD) Vaccines Product Table 154. MSD Animal Health Recent Developments Table 155. CEVA Corporation Information Table 156. CEVA Description and Major Businesses Table 157. CEVA Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2016-2021) Table 158. CEVA Foot and Mouth Disease (FMD) Vaccines Product Table 159. CEVA Recent Developments Table 160. FGBI Corporation Information Table 161. FGBI Description and Major Businesses Table 162. FGBI Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2016-2021) Table 163. FGBI Foot and Mouth Disease (FMD) Vaccines Product Table 164. FGBI Recent Developments Table 165. Bayer HealthCare Corporation Information Table 166. Bayer HealthCare Description and Major Businesses Table 167. Bayer HealthCare Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2016-2021) Table 168. Bayer HealthCare Foot and Mouth Disease (FMD) Vaccines Product Table 169. Bayer HealthCare Recent Developments Table 170. Brilliant Bio Pharma Corporation Information Table 171. Brilliant Bio Pharma Description and Major Businesses Table 172. Brilliant Bio Pharma Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2016-2021) Table 173. Brilliant Bio Pharma Foot and Mouth Disease (FMD) Vaccines Product Table 174. Brilliant Bio Pharma Recent Developments Table 175. VECOL Corporation Information Table 176. VECOL Description and Major Businesses Table 177. VECOL Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2016-2021) Table 178. VECOL Foot and Mouth Disease (FMD) Vaccines Product Table 179. VECOL Recent Developments Table 180. Sanofi (Merial) Corporation Information Table 181. Sanofi (Merial) Description and Major Businesses Table 182. Sanofi (Merial) Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2016-2021) Table 183. Sanofi (Merial) Foot and Mouth Disease (FMD) Vaccines Product Table 184. Sanofi (Merial) Recent Developments Table 185. VETAL Corporation Information Table 186. VETAL Description and Major Businesses Table 187. VETAL Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2016-2021) Table 188. VETAL Foot and Mouth Disease (FMD) Vaccines Product Table 189. VETAL Recent Developments Table 190. BVI Corporation Information Table 191. BVI Description and Major Businesses Table 192. BVI Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2016-2021) Table 193. BVI Foot and Mouth Disease (FMD) Vaccines Product Table 194. BVI Recent Developments Table 195. LIMOR Corporation Information Table 196. LIMOR Description and Major Businesses Table 197. LIMOR Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2016-2021) Table 198. LIMOR Foot and Mouth Disease (FMD) Vaccines Product Table 199. LIMOR Recent Developments Table 200. ME VAC Corporation Information Table 201. ME VAC Description and Major Businesses Table 202. ME VAC Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2016-2021) Table 203. ME VAC Foot and Mouth Disease (FMD) Vaccines Product Table 204. ME VAC Recent Developments Table 205. Agrovet Corporation Information Table 206. Agrovet Description and Major Businesses Table 207. Agrovet Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2016-2021) Table 208. Agrovet Foot and Mouth Disease (FMD) Vaccines Product Table 209. Agrovet Recent Developments Table 210. Key Raw Materials Lists Table 211. Raw Materials Key Suppliers Lists Table 212. Foot and Mouth Disease (FMD) Vaccines Distributors List Table 213. Foot and Mouth Disease (FMD) Vaccines Customers List Table 214. Foot and Mouth Disease (FMD) Vaccines Market Trends Table 215. Foot and Mouth Disease (FMD) Vaccines Market Drivers Table 216. Foot and Mouth Disease (FMD) Vaccines Market Challenges Table 217. Foot and Mouth Disease (FMD) Vaccines Market Restraints Table 218. Research Programs/Design for This Report Table 219. Key Data Information from Secondary Sources Table 220. Key Data Information from Primary Sources List of Figures Figure 1. Foot and Mouth Disease (FMD) Vaccines Product Picture Figure 2. Global Foot and Mouth Disease (FMD) Vaccines Market Share by Type in 2020 & 2027 Figure 3. Emergency Vaccines Product Picture Figure 4. Conventional Vaccines Product Picture Figure 5. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Application in 2020 & 2027 Figure 6. Cattle Figure 7. Pig Figure 8. Sheep & Goat Figure 9. Others Figure 10. Foot and Mouth Disease (FMD) Vaccines Report Years Considered Figure 11. Global Foot and Mouth Disease (FMD) Vaccines Sales 2016-2027 (K L) Figure 12. Global Foot and Mouth Disease (FMD) Vaccines Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global Foot and Mouth Disease (FMD) Vaccines Revenue 2016-2027 (US$ Million) Figure 14. Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Region in Percentage: 2020 Versus 2027 Figure 15. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Region (2016-2021) Figure 16. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Region (2022-2027) Figure 17. North America Foot and Mouth Disease (FMD) Vaccines Sales YoY (2016-2027) & (K L) Figure 18. North America Foot and Mouth Disease (FMD) Vaccines Revenue YoY (2016-2027) & (US$ Million) Figure 19. Europe Foot and Mouth Disease (FMD) Vaccines Sales YoY (2016-2027) & (K L) Figure 20. Europe Foot and Mouth Disease (FMD) Vaccines Revenue YoY (2016-2027) & (US$ Million) Figure 21. Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Sales YoY (2016-2027) & (K L) Figure 22. Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Revenue YoY (2016-2027) & (US$ Million) Figure 23. Latin America Foot and Mouth Disease (FMD) Vaccines Sales YoY (2016-2027) & (K L) Figure 24. Latin America Foot and Mouth Disease (FMD) Vaccines Revenue YoY (2016-2027) & (US$ Million) Figure 25. Middle East & Africa Foot and Mouth Disease (FMD) Vaccines Sales YoY (2016-2027) & (K L) Figure 26. Middle East & Africa Foot and Mouth Disease (FMD) Vaccines Revenue YoY (2016-2027) & (US$ Million) Figure 27. The Top 10 and Top 5 Players Market Share by Foot and Mouth Disease (FMD) Vaccines Sales in 2020 Figure 28. The Top 10 and Top 5 Players Market Share by Foot and Mouth Disease (FMD) Vaccines Revenue in 2020 Figure 29. Foot and Mouth Disease (FMD) Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020 Figure 30. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Type (2016-2027) Figure 31. Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Type (2016-2027) Figure 32. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Application (2016-2027) Figure 33. Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Application (2016-2027) Figure 34. North America Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Type (2016-2027) Figure 35. North America Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Type (2016-2027) Figure 36. North America Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Application (2016-2027) Figure 37. North America Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Application (2016-2027) Figure 38. North America Foot and Mouth Disease (FMD) Vaccines Sales Share by Country (2016-2027) Figure 39. North America Foot and Mouth Disease (FMD) Vaccines Revenue Share by Country (2016-2027) Figure 40. U.S. Foot and Mouth Disease (FMD) Vaccines Revenue (2016-2027) & (US$ Million) Figure 41. Canada Foot and Mouth Disease (FMD) Vaccines Revenue (2016-2027) & (US$ Million) Figure 42. Europe Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Type (2016-2027) Figure 43. Europe Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Type (2016-2027) Figure 44. Europe Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Application (2016-2027) Figure 45. Europe Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Application (2016-2027) Figure 46. Europe Foot and Mouth Disease (FMD) Vaccines Sales Share by Country (2016-2027) Figure 47. Europe Foot and Mouth Disease (FMD) Vaccines Revenue Share by Country (2016-2027) Figure 48. Germany Foot and Mouth Disease (FMD) Vaccines Revenue (2016-2027) & (US$ Million) Figure 49. France Foot and Mouth Disease (FMD) Vaccines Revenue (2016-2027) & (US$ Million) Figure 50. U.K. Foot and Mouth Disease (FMD) Vaccines Revenue (2016-2027) & (US$ Million) Figure 51. Italy Foot and Mouth Disease (FMD) Vaccines Revenue (2016-2027) & (US$ Million) Figure 52. Russia Foot and Mouth Disease (FMD) Vaccines Revenue (2016-2027) & (US$ Million) Figure 53. Asia Pacific Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Type (2016-2027) Figure 54. Asia Pacific Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Type (2016-2027) Figure 55. Asia Pacific Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Application (2016-2027) Figure 56. Asia Pacific Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Application (2016-2027) Figure 57. Asia Pacific Foot and Mouth Disease (FMD) Vaccines Sales Share by Region (2016-2027) Figure 58. Asia Pacific Foot and Mouth Disease (FMD) Vaccines Revenue Share by Region (2016-2027) Figure 59. China Foot and Mouth Disease (FMD) Vaccines Revenue (2016-2027) & (US$ Million) Figure 60. Japan Foot and Mouth Disease (FMD) Vaccines Revenue (2016-2027) & (US$ Million) Figure 61. South Korea Foot and Mouth Disease (FMD) Vaccines Revenue (2016-2027) & (US$ Million) Figure 62. India Foot and Mouth Disease (FMD) Vaccines Revenue (2016-2027) & (US$ Million) Figure 63. Australia Foot and Mouth Disease (FMD) Vaccines Revenue (2016-2027) & (US$ Million) Figure 64. Taiwan Foot and Mouth Disease (FMD) Vaccines Revenue (2016-2027) & (US$ Million) Figure 65. Indonesia Foot and Mouth Disease (FMD) Vaccines Revenue (2016-2027) & (US$ Million) Figure 66. Thailand Foot and Mouth Disease (FMD) Vaccines Revenue (2016-2027) & (US$ Million) Figure 67. Malaysia Foot and Mouth Disease (FMD) Vaccines Revenue (2016-2027) & (US$ Million) Figure 68. Philippines Foot and Mouth Disease (FMD) Vaccines Revenue (2016-2027) & (US$ Million) Figure 69. Latin America Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Type (2016-2027) Figure 70. Latin America Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Type (2016-2027) Figure 71. Latin America Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Application (2016-2027) Figure 72. Latin America Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Application (2016-2027) Figure 73. Latin America Foot and Mouth Disease (FMD) Vaccines Sales Share by Country (2016-2027) Figure 74. Latin America Foot and Mouth Disease (FMD) Vaccines Revenue Share by Country (2016-2027) Figure 75. Mexico Foot and Mouth Disease (FMD) Vaccines Revenue (2016-2027) & (US$ Million) Figure 76. Brazil Foot and Mouth Disease (FMD) Vaccines Revenue (2016-2027) & (US$ Million) Figure 77. Argentina Foot and Mouth Disease (FMD) Vaccines Revenue (2016-2027) & (US$ Million) Figure 78. Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Type (2016-2027) Figure 79. Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Type (2016-2027) Figure 80. Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Application (2016-2027) Figure 81. Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Application (2016-2027) Figure 82. Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Sales Share by Country (2016-2027) Figure 83. Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Revenue Share by Country (2016-2027) Figure 84. Turkey Foot and Mouth Disease (FMD) Vaccines Revenue (2016-2027) & (US$ Million) Figure 85. Saudi Arabia Foot and Mouth Disease (FMD) Vaccines Revenue (2016-2027) & (US$ Million) Figure 86. U.A.E Foot and Mouth Disease (FMD) Vaccines Revenue (2016-2027) & (US$ Million) Figure 87. Foot and Mouth Disease (FMD) Vaccines Value Chain Figure 88. Foot and Mouth Disease (FMD) Vaccines Production Process Figure 89. Channels of Distribution Figure 90. Distributors Profiles Figure 91. Bottom-up and Top-down Approaches for This Report Figure 92. Data Triangulation Figure 93. Key Executives Interviewed

Jinyu Group Cavet Bio Indian Immunologicals Tecon Group CAHIC Shen Lian Biogenesis Bagó BIGVET Biotech Boehringer Ingelheim MSD Animal Health CEVA FGBI Bayer HealthCare Brilliant Bio Pharma VECOL Sanofi (Merial) VETAL BVI LIMOR ME VAC Agrovet